Skip to main content
. Author manuscript; available in PMC: 2016 Mar 1.
Published in final edited form as: Am J Hematol. 2014 Nov 24;90(3):187–192. doi: 10.1002/ajh.23888

Table 2.

Clinical symptoms at baseline and after total splenectomy or partial splenectomy for children with hereditary spherocytosis or sickle cell disease

Hereditary spherocytosis Sickle cell disease
Baseline Postop p-value Baseline Postop p-value
Splenic sequestration 8 (20%) 1 (2.6%) 0.034 45 (90%) 1 (2.1%) <0.001

Transfusions 8 (20%) 0 (0%) 0.005 13 (26%) 1 (2%) <0.001

Aplastic or anemic crisis 5 (12.5%) NR NR NR

Hypersplenism 0 (0%) NR 4 (8%) NR

Splenomegaly 11 (27.5%) 0 (0%) <0.001 5 (10%) 0 (0%) 0.025

Numbers represent counts (%) for symptoms at baseline and postoperatively for children with hereditary spherocytosis or sickle cell disease following total splenectomy or partial splenectomy. Transfusions-History of transfusions or participation in regular transfusion program. p-values represent McNemar’s for matched pair differences between baseline and postoperative symptoms. Any symptom reported during 1 year follow-up was counted as having a postoperative symptom, with multiple episodes during follow-up counted only once. NR-Not recorded